new england journal of medicine semaglutide Once-Weekly in Adults with Overweight or Obesity Cardiac Trials | ~~ Most
Description
Nausea was observed in 23.5% of patients receiving dulaglutide and 27.3% of those receiving semaglutide
Other barriers include inconsistent adherence, unaddressed hormonal imbalances, or underlying insulin resistance that semaglutide alone cannot fully resolve
The safest generalization is that the GLP-1 arm of tirzepatide probably behaves like dulaglutide on cortisol: neutral
References Laaksonen, D
BMI z-scores are a poor indicator of adiposity among 2- to 19-year-olds with very high BMIs, NHANES 1999-2000 to 2013-2014
Research framings commonly use morning, once daily
